Introduction: The contribution of clinical investigations to prediction of long-term outcomes 43 of children investigated for asthma is unclear. 44
Introduction 67
Asthma is the most prevalent chronic respiratory disease in childhood and adolescence, 68 which leads to many health care visits.(1-3) Its key symptoms are wheeze, cough, and 69 difficulty breathing, but symptoms vary substantially between individuals and across ages. (1, 70 2) Some children who present with asthma symptoms continue to have problems later in life, 71 while others do not. Better knowledge of their individual prognoses might affect their follow-72 up and answer questions of parents in the clinics.(4-6) Assessing prognosis of asthma 73 symptoms from school age into adulthood and identifying children at high-risk of symptom 74 persistence is challenging.(4) 75
Studies investigating prognosis of asthma or wheeze in school-aged children are conducted 76 with either clinical asthma cohorts or symptomatic children of a population-based cohort.(7) 77
Studies in clinical asthma cohorts have found that lower FEV1, asthma severity, sensitisation 78 to indoor allergens, eczema, hay fever, skin test reactivity, and bronchial hyper-79 responsiveness were associated with asthma persistence.(8-10) Studies in population-based 80 cohorts have found that wheeze persistence was predicted by frequent attacks of wheeze, 81 female sex, sensitization to furred animals or house dust mites, rhinitis, and bronchial hyper-82 responsiveness.(11-16) 83
For clinical practice, two knowledge gaps remain. First, few studies have examined the 84 prediction of long-term prognosis, but none have done this for school-aged children seen in 85 outpatient clinics for possible asthma. Second, many tests are performed in clinics to 86 diagnose these children, but it is unclear whether these tests predict prognosis more 87 accurately than reported symptoms alone. We determined whether clinical tests in addition 88 to reported symptoms help predict wheeze in adolescence in school-aged children referred 89 for possible asthma. The follow-up questionnaire was very similar to the baseline questionnaire, but the questions 132
were addressed directly to the adolescents instead of their parents. 133 134
Definitions of wheeze and frequent wheeze 135
We assessed wheeze at follow-up with the question, "Have you had a whistling sound in the 136 chest in the last 12 months?" If a child had had more than three attacks of wheeze in the last 137 12 months, we considered the child to have had frequent wheeze. 138 139
Statistical analysis 140
We compared the participants with information at baseline and follow-up to those without 141 follow-up information to test for selection bias, using chi-square test. The participants with 142 information at baseline and follow-up were included in the analysis. 143
We investigated the association between exercise-induced wheeze and a positive exercise 144 test at baseline using the Fisher's exact test, and the Mann-Whitney-U test when looking at 145 the association of reported exercise-induced wheeze and the fall of FEV1% predicted during 146 the exercise test. 147
We investigated the association between symptoms and clinical test results at baseline with 148 any wheeze and frequent wheeze at follow-up using logistic regression. We included all 149 symptoms from table 1 and clinical tests from table 2 in the model and adjusted for sex and  150 age. We did not consider interactions because of the sample size. We used STATA software 151 (version 14; College Station, Texas) to analyse the data. 152
153

Results
154
Characteristics of the study population at baseline and at follow-up 155
Eighty-five (77%) of the 111 children who participated in the baseline study completed the 156 follow-up questionnaire. The median age was 12 years at baseline (range 6-16) and 18 at 157 follow-up (12-23); 60% (51/85) were male. Wheeze was reported by 61 (72%) at baseline, 158 and 7 reported cough without wheeze and 12 (14%) reported exercise-related breathing 159 problems. Among those with wheeze, 27 (44%) had more than three attacks during 12 160 months prior to the baseline visit (Table 1) . Symptoms at baseline were very similar in 161 children who did not take part in the follow-up (Table S1 online supplementary material). 162
Asthma medication was prescribed at the baseline visit for 71 (85%) children, of whom 47 163 (55%) received inhaled short-acting β2-agonists (SABA) alone, 6 received SABA and 164 inhaled corticosteroids (ICS), and 18 received long-acting β2-agonists (LABA) and ICS. At 165 follow-up, 39 (46%) participants reported wheeze of whom 30 had more than 3 attacks 166 during the last year. At follow-up, 44 adolescents (52%) reported using inhalers, including 21 167 using SABA alone, 2 using SABA and ICS, and 21 using LABA and ICS (Table 1) . 168 169 At baseline, self-reported exercise-induced wheeze was associated with a positive exercise 186 test (p=0.022, table S2). Self-reported exercise-induced wheeze was also associated with 187 the fall of FEV1% predicted during the exercise test (p=0.003, figure S1) 188 189 
Discussion
218
Among school-aged children referred to a respiratory outpatient clinic for evaluation of 219 wheeze, cough, or dyspnoea, 46% reported wheeze seven years later. Reported exercise-220 induced wheeze and wheeze triggered by pets or pollen at baseline predicted wheeze at 221 follow-up. Of the clinical tests, only a positive exercise challenge test predicted wheeze at 222 follow-up, but no more strongly than reported exercise-induced wheeze. 223
A few studies have examined the prediction of prognosis by clinical testing, but ours is the 224 only study to have done this for so many clinical tests in school-aged children referred to a 225 respiratory outpatient clinic. We did not find an association between FEV1 at baseline and 226 wheeze seven years later; previous studies have reported contradictory findings. Both the 227 CAMP cohort of 909 children aged 5-12 years with diagnosed asthma and another Dutch 228 clinical cohort study of 5-14 year-old children diagnosed with asthma found that asthma 229 persistence at ages 15-20 and 32-42, respectively, was associated with decreased FEV1 at 230 school-age. (8, 9) In contrast, the population-based Tasmanian cohort did not find an 231 association between FEV1 at age 7 and wheeze persistence at age 29-32.(12, 15) This 232 could be because children with wheeze from population-based cohorts might have milder 233 asthma than those in clinical studies. Our findings are not directly comparable with those of 234 other studies that studied younger children, reported test results differently, or included 235 healthy children. 236
Our observation that frequent attacks of wheeze at school age predicted wheeze persistence 237 seven years later is in line with findings from the Melbourne and Tasmanian cohorts.(10, 11) 238
In contrast to their findings, we found no significant association between either eczema or 239 hay fever at baseline and wheeze persistence. This could be because those cohorts used 240 different outcomes-severe wheeze and atopic asthma, respectively-or simply because we 241 had low numbers and limited power. 242
A possible limitation of our study was that the bronchial provocation tests were done within a 243 short period of time. This could have influenced the methacholine test result, which was 244 performed after the exercise test on the same day and was positive in 76% of the children. 245
Most likely the bronchial provocation test by mannitol was not influenced by the short time 246
interval. We assured an appropriate interval of at least 24 hours without a change in 247 respiratory health or medication in this time interval. A second limitation was the small 248 sample size, which limited statistical power and did not allow us to perform a multivariable 249 analysis including all symptoms and test results simultaneously. 250
The main strength of our study is its clinical design, which reflects the typical mix of patients 251 in a paediatric outpatient clinic. All children were first-time referrals to the paediatric 252 respiratory clinic for evaluation of possible asthma. Therefore, the study population is 253 representative of daily clinical work, in contrast to many clinical studies that selectively 254 include well-defined moderate to severe asthmatics and leave out patients with unclear 255 degrees of airway reactivity. Our study also profited from a very detailed baseline 256 examination. Children in the study had an extensive array of examinations for lung function, 257
BPT and allergy, which allowed us to assess the contribution of clinical tests in predicting 258 long-term wheeze in addition to reported symptoms among those referred for evaluation of 259 possible asthma. 260 261
Conclusion 262
This study is an initial step towards finding out whether clinical tests can predict wheeze later 263 in life. Though clinical tests might be important for asthma diagnosis, our results suggest that 264 they do not strongly predict prognosis of wheeze. In contrast, our data underline the 265 importance of a detailed history, as school-age children reporting exercise-related wheeze 
